These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 20004268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [Abstract] [Full Text] [Related]

  • 4. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S, Kaye JA, Li L, Jick H.
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [Abstract] [Full Text] [Related]

  • 5. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec 16; 346(8990):1582-8. PubMed ID: 7500749
    [Abstract] [Full Text] [Related]

  • 11. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM, Siscovick DS, Longstreth WT, Psaty BM, Beverly RK, Raghunathan TE, Lin D, Koepsell TD.
    Ann Intern Med; 1997 Oct 15; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 16. The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database.
    Jick SS, Hagberg KW, Kaye JA, Jick H.
    Contraception; 2009 Aug 15; 80(2):142-51. PubMed ID: 19631789
    [Abstract] [Full Text] [Related]

  • 17. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA, Norman H, Doherty M, Walker AM.
    Obstet Gynecol; 2007 Feb 15; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [Abstract] [Full Text] [Related]

  • 18. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.
    Dore DD, Norman H, Loughlin J, Seeger JD.
    Contraception; 2010 May 15; 81(5):408-13. PubMed ID: 20399947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.